Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
4.2.2 Increasing Investments in R&D for Drug Discovery
4.2.3 Rise in Technological Advancements in Cell-based Methodologies
4.3 Market Restraints
4.3.1 High Maintenance and Operational Costs
4.3.2 Lack of Skilled Personnel to Operate these Technologies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Cell Lines
5.1.1.1 Primary Cell Lines
5.1.1.2 Stem Cell Lines
5.1.1.3 Others
5.1.2 Reagents and Kits
5.1.3 Microplates
5.1.4 Other Consumables
5.2 By Technology
5.2.1 Automated Handling
5.2.2 Flow Cytometry
5.2.3 Label-free Detection
5.2.4 High-throughput Screening
5.2.5 Others
5.3 By Application
5.3.1 Drug Discovery
5.3.2 Other Applications
5.4 By End-user
5.4.1 Academic & Government Institutes
5.4.2 Pharmaceutical and Biotechnology Companies
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Corning Inc.
6.1.4 Danaher Corporation
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 Merck KGaA
6.1.8 Perkin Elmer Inc.
6.1.9 Promega Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS